Lee SW, Kim HC, Lee HS, Suh I. Thirty-year trends in mortality from cardiovascular diseases in Korea. Korean Circ J 2015; 45: 202-9.
Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation 2014; 129: e28-292.
Committee for the Korean Guidelines for the Management of Dyslipidemia. 2015 Korean Guidelines for the Management of Dyslipidemia: Executive Summary (English Translation). Korean Circ J 2016; 46: 275-306.
Park SC, Oh MY, Kim HS. A study on usage of health improving agents in Seoul & Busan. J Korean Diet Assoc 2005; 11: 440-8.
Khan N, Mukhtar H. Tea polyphenols for health promotion. Life Sci 2007;81: 519-33.
Lim KH, Jeon SE, Choi MN. Review of Effectiveness of Green Tea Epigallocatechin Gallate (EGCG) on the inside and outside of human body. Korean J Aesthet Cosmetol 2015; 13: 701-11.
Kawada T. Green tea consumption and risk of cardiovascular disease or stroke. Int J Cardiol 2016; 221: 831.
Zhang C, Qin YY, Wei X, Yu FF, Zhou YH, He J. Tea consumption and risk of cardiovascular outcomes and total mortality: a systematic review and metaanalysis of prospective observational studies. Eur J Epidemiol 2015; 30: 103-13.
Mineharu Y, Koizumi A, Wada Y, Iso H, Watanabe Y, Date C, et al. Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women. J Epidemiol Community Health 2011; 65: 230-40.
Hsu CH, Tsai TH, Kao YH, Hwang KC, Tseng TY, Chou P. Effect of green tea extract on obese women: a randomized, double-blind, placebo-controlled clinical trial. Clin Nutr 2008; 27: 363-70.
Tokunaga S, White IR, Frost C, Tanaka K, Kono S, Tokudome S, et al. Green tea consumption and serum lipids and lipoproteins in a population of healthy workers in Japan. Ann Epidemiol 2002; 12: 157-65.
Imai K, Nakachi K. Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. BMJ 1995; 310: 693-6.
Kono S, Shinchi K, Ikeda N, Yanai F, Imanishi K. Green tea consumption and serum lipid profiles: a cross-sectional study in northern Kyushu, Japan. Prev Med 1992; 21: 526-31.
Kono S, Shinchi K, Wakabayashi K, Honjo S, Todoroki I, Sakurai Y, et al. Relation of green tea consumption to serum lipids and lipoproteins in Japanese men. J Epidemiol 1996; 6: 128-33.
Zheng XX, Xu YL, Li SH, Liu XX, Hui R, Huang XH. Green tea intake lowers fasting serum total and LDL cholesterol in adults: a meta-analysis of 14 randomized controlled trials. Am J Clin Nutr 2011; 94: 601-10.
Kim A, Chiu A, Barone MK, Avino D, Wang F, Coleman CI, et al. Green tea catechins decrease total and low-density lipoprotein cholesterol: a systematic review and meta-analysis. J Am Diet Assoc 2011; 111: 1720-9.
Onakpoya I, Spencer E, Heneghan C, Thompson M. The effect of green tea on blood pressure and lipid profile: a systematic review and meta-analysis of randomized clinical trials. Nutr Metab Cardiovasc Dis 2014; 24: 823-36.
Khalesi S, Sun J, Buys N, Jamshidi A, Nikbakht-Nasrabadi E, KhosraviBoroujeni H. Green tea catechins and blood pressure: a systematic review and meta-analysis of randomised controlled trials. Eur J Nutr 2014; 53:1299-311.
Juhel C, Armand M, Pafumi Y, Rosier C, Vandermander J, Lairon D. Green tea extract (AR25) inhibits lipolysis of triglycerides in gastric and duodenal medium in vitro. J Nutr Biochem 2000; 11: 45-51.
Wang S, Noh SK, Koo SI. Green tea catechins inhibit pancreatic phospholipase A2 and intestinal absorption of lipids in ovariectomized rats. J Nutr Biochem 2006; 17: 492-8.